Display Accessibility Tools

Accessibility Tools


Highlight Links

Change Contrast

Increase Text Size

Increase Letter Spacing

Dyslexia Friendly Font

Increase Cursor Size

2013 - "Apoptosis" Programmed Cell Death

The Genetics Graduate Program

at Michigan State University


Presents a Symposium On


Programmed Cell Death


Tuesday, May 7, 2013
8:30 a.m. to 5:00 p.m.

Molecular Plant Science Building
Michigan State University

Click here for list of Poster Presenters

2013 Speakers:


Jody Rosenblatt

Jody Rosenblatt, Ph.D.

Associate Professor, Oncological Sciences
Huntsman Cancer Institute,
University of Utah

On apoptosis, we have discovered a process for how apoptotic cells are eliminated from the epithelium without compromising the epithelial barrier function. Here, the dying cell sends signals to its live neighbors, which respond by forming an actin and myosin ring that contracts to squeeze the dying cell out.

Cindy Miranti

Cindy Miranti, Ph.D.
Associate Professor
Center for Cancer and Cell Biology
Van Andel Research Institute

Studies the mechanisms through which a cell interacts with its environment and receives signals from other parts of the body, particularly, the study of integrins. How integrins receive and process signals that lead to the deregulation of cellular migration, survival and proliferation is a major question the lab is pursuing, in particular with regard to metastatic prostate cancer.

Andreas Bergmann

Andreas Bergmann Ph.D.
Professor, Department of Cancer Biology
University of Massachusetts Medical School

Genetic Control of Programmed Cell Death (Apoptosis) in Drosophila. The long-term objective of our research is to gain a comprehensive understanding of the genetic control of apoptosis and cell proliferation, and their connection to human cancer and neurodegeneration.

Anthony G. Letai

Anthony G. Letai, MD, Ph.D.
Associate Professor of Medicine
Hematologic Oncology
Harvard Medical School

Dr. Letai's research focuses on the mechanisms by which cancer cells evade death, and on the application of that knowledge to the selective killing of cancer cells.